Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
Status:
Suspended
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of Pegamotecan
(Peg-Camptothecin) in patients with Advanced or Metastatic Soft Tissue sarcoma.